Virtual assets and FATF guidelines – a risk-based approach for financial institutions
Name:
Allergan Middle East Ltd.
Trading Name:
Allergan Middle East
Status of Registration:
Active
Type of License:
Non Regulated
Legal Structure:
Private Company
Date of Incorporation :
27 02 2017
Commercial License Validity Date:
26 02 2022
Directors:
Mir Djamshid Ghavami
Eliane Mouawad
Reginald Masimba Mudangwe
Oleg Zujev
Shareholders:
Allergan Holdings Limited
Company Secretary:
Faizal Latheef
DNFBP:
Designated Non-Financial Businesses and Professions
No
Financial Year End:
31st December
Auditor:
Ernst & Young Middle East (Dubai Branch)
Class of Issued Shares:
A
Nominal Value of One Share:
USD 500.000000
Number of Issued Shares:
100.000000
Data Protection Officer Appointed:
No
Notifications:
Personal Data Processing Operations:
No
Transfer of Personal Data from the DIFC:
No
Processing of Special Categories of Personal Data:
No
Company Secretary:
Adel Khalaf until 05 July 2020
Directors:
Ahmed Samy until 05 November 2018
Umberto La Magna until 19 November 2017
Gavin Scott Morant Smith until 16 May 2017
Maha Mostafa Ahmed Shafik until 18 June 2017
Jason Smith until 28 February 2018
Ramsey Morad until 27 May 2020
Rasha El Hibri until 20 December 2020
Scan the QR code for
direct download
Scan the QR code for
direct download
For better web experience, please use the website in portrait mode
